A new strategy capable of directly killing cancer cells and concurrently boosting anti-tumor immunity for the effective treatment of triple-negative breast cancer
A new strategy capable of directly killing cancer cells and concurrently boosting anti-tumor immunity for the effective treatment of triple-negative breast cancer
一种能够直接杀死癌细胞并同时增强抗肿瘤免疫力的新策略，有效治疗三阴性乳腺癌
批准号：
486387
负责人：
Kirkby Melanie D
金额：
$1.27万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-12-01 至 2023-12-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Breast cancer remains a leading cause of death in women in the world. Triple negative breast cancer (TNBC) accounts for only 15-20% of all breast cancers but disproportionately accounts for the majority of breast cancer related deaths. TNBC patients are p
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
